Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | YRDC |
| Upstream (Parents) |
|---|
| (<<) ASB1 → YRDC |
| (<<) DVL1 → YRDC |
| (<<) ELOVL1 → YRDC |
| (<<) EPHA2 → YRDC |
| (<<) FOSL1 → YRDC |
| (<<) HSP90AA1 → YRDC |
| (<<) ILKAP → YRDC |
| (<<) KLHL7 → YRDC |
| (<<) LRP8 → YRDC |
| (<<) PIK3R1 → YRDC |
| (<<) PLCB3 → YRDC |
| (<<) RHOC → YRDC |
| (<<) RRP9 → YRDC |
| (<<) TCEB1 → YRDC |
| (<<) TUBA4A → YRDC |
| Downstream (Children) |
|---|
| YRDC → ARSJ (>>) |
| YRDC → CD79A (>>) |
| YRDC → CDKN2A (>>) |
| YRDC → CXCL14 (>>) |
| YRDC → DUSP5 (>>) |
| YRDC → KCTD5 (>>) |
| YRDC → MAP2K3 (>>) |
| YRDC → PITPNA (>>) |
| YRDC → RPS6KB1 (>>) |
| YRDC → RPS6KB2 (>>) |
| YRDC → TAF9 (>>) |
| YRDC → TXNIP (>>) |
